George E. Dukes

4.2k total citations
97 papers, 3.1k citations indexed

About

George E. Dukes is a scholar working on Gastroenterology, Surgery and Physiology. According to data from OpenAlex, George E. Dukes has authored 97 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Gastroenterology, 31 papers in Surgery and 20 papers in Physiology. Recurrent topics in George E. Dukes's work include Gastrointestinal motility and disorders (36 papers), Helicobacter pylori-related gastroenterology studies (16 papers) and Pharmaceutical studies and practices (11 papers). George E. Dukes is often cited by papers focused on Gastrointestinal motility and disorders (36 papers), Helicobacter pylori-related gastroenterology studies (16 papers) and Pharmaceutical studies and practices (11 papers). George E. Dukes collaborates with scholars based in United States, United Kingdom and Sweden. George E. Dukes's co-authors include David McSorley, Allison R. Northcutt, Allen W. Mangel, Michael Camilleri, Emeran A. Mayer, Amy Heath, William Y. Chey, Peter J. Whorwell, Robert E. Spiller and J. Robert Powell and has published in prestigious journals such as The Lancet, Journal of Neuroscience and Annals of Internal Medicine.

In The Last Decade

George E. Dukes

93 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George E. Dukes United States 28 1.6k 1.0k 897 368 322 97 3.1k
Sanjiv Mahadeva Malaysia 36 1.6k 1.0× 1.6k 1.6× 558 0.6× 237 0.6× 187 0.6× 168 4.8k
J. Næsdal Sweden 26 1.7k 1.1× 1.3k 1.3× 429 0.5× 69 0.2× 146 0.5× 54 3.0k
Andrés Acosta United States 38 1.2k 0.7× 1.9k 1.9× 1.5k 1.7× 273 0.7× 103 0.3× 151 4.4k
Erik Muls Belgium 27 377 0.2× 737 0.7× 799 0.9× 244 0.7× 227 0.7× 76 2.9k
P. E. Harding Australia 21 1.2k 0.8× 953 0.9× 1.1k 1.2× 160 0.4× 135 0.4× 41 2.7k
Bart Morlion Belgium 34 420 0.3× 1.0k 1.0× 1.4k 1.5× 418 1.1× 100 0.3× 109 4.4k
Birgitte Brock Denmark 34 228 0.1× 1.2k 1.2× 977 1.1× 312 0.8× 78 0.2× 129 4.6k
Enrique Rey Spain 29 1.4k 0.9× 1.2k 1.2× 299 0.3× 21 0.1× 134 0.4× 141 2.6k
Lynn R. Webster United States 42 1.1k 0.7× 1.7k 1.7× 1.8k 2.0× 34 0.1× 117 0.4× 237 7.3k
Lorcan McGarvey United Kingdom 42 830 0.5× 548 0.5× 4.3k 4.8× 196 0.5× 142 0.4× 184 7.3k

Countries citing papers authored by George E. Dukes

Since Specialization
Citations

This map shows the geographic impact of George E. Dukes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George E. Dukes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George E. Dukes more than expected).

Fields of papers citing papers by George E. Dukes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George E. Dukes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George E. Dukes. The network helps show where George E. Dukes may publish in the future.

Co-authorship network of co-authors of George E. Dukes

This figure shows the co-authorship network connecting the top 25 collaborators of George E. Dukes. A scholar is included among the top collaborators of George E. Dukes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George E. Dukes. George E. Dukes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boeckxstaens, Guy E., Sabry Ayad, George E. Dukes, et al.. (2024). A randomized phase 2 study of the 5-HT4 receptor agonist felcisetrag for postoperative gastrointestinal dysfunction after bowel surgery. The American Journal of Surgery. 234. 162–171. 1 indexed citations
2.
Cao, Zhun, et al.. (2023). Incidence and risk factors for postoperative gastrointestinal dysfunction occurrence after gastrointestinal procedures in US patients. The American Journal of Surgery. 226(5). 675–681. 5 indexed citations
3.
Hellström, Per M., Jan Tack, Kimberley Hacquoil, et al.. (2016). The pharmacodynamics, safety and pharmacokinetics of single doses of the motilin agonist, camicinal, in type 1 diabetes mellitus with slow gastric emptying. British Journal of Pharmacology. 173(11). 1768–1777. 27 indexed citations
4.
Hegade, Vinod S., Stuart Kendrick, Robert L. Dobbins, et al.. (2016). BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trial. BMC Gastroenterology. 16(1). 71–71. 33 indexed citations
5.
Hobson, Ruth M., Adam D. Farmer, Odile Dewit, et al.. (2015). The effects of camicinal, a novel motilin agonist, on gastro‐esophageal function in healthy humans—a randomized placebo controlled trial. Neurogastroenterology & Motility. 27(11). 1629–1637. 15 indexed citations
6.
Gungabissoon, Usha, Kimberley Hacquoil, Chanchal Bains, et al.. (2014). Prevalence, Risk Factors, Clinical Consequences, and Treatment of Enteral Feed Intolerance During Critical Illness. Journal of Parenteral and Enteral Nutrition. 39(4). 441–448. 179 indexed citations
7.
Swan, Caroline, Nathalie P. Duroudier, Eugene Campbell, et al.. (2012). Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα. Gut. 62(7). 985–994. 131 indexed citations
8.
Arebi, Naila, et al.. (2011). Distinct neurophysiological profiles in irritable bowel syndrome. American Journal of Physiology-Gastrointestinal and Liver Physiology. 300(6). G1086–G1093. 9 indexed citations
9.
Hubbard, Catherine S., Jennifer S. Labus, Joshua A. Bueller, et al.. (2011). Corticotropin-Releasing Factor Receptor 1 Antagonist Alters Regional Activation and Effective Connectivity in an Emotional–Arousal Circuit during Expectation of Abdominal Pain. Journal of Neuroscience. 31(35). 12491–12500. 77 indexed citations
10.
Schmith, Virginia D., Brendan M. Johnson, Lakshmi Vasist, et al.. (2009). The Effects of a Short Course of Antibiotics on Alvimopan and Metabolite Pharmacokinetics. The Journal of Clinical Pharmacology. 50(3). 338–349. 2 indexed citations
11.
Grudell, April, Michael Camilleri, Kimberly L. Jensen, et al.. (2008). Dose-response effect of a β3-adrenergic receptor agonist, solabegron, on gastrointestinal transit, bowel function, and somatostatin levels in health. American Journal of Physiology-Gastrointestinal and Liver Physiology. 294(5). G1114–G1119. 27 indexed citations
12.
Houghton, Lesley A., Filippo Cremonini, Michael Camilleri, et al.. (2007). Effect of the NK3receptor antagonist, talnetant, on rectal sensory function and compliance in healthy humans. Neurogastroenterology & Motility. 19(9). 732–743. 36 indexed citations
13.
Chey, William D., William Y. Chey, Amy Heath, et al.. (2004). Long-Term Safety and Efficacy of Alosetron in Women with Severe Diarrhea-Predominant Irritable Bowel Syndrome. The American Journal of Gastroenterology. 99(11). 2195–2203. 116 indexed citations
14.
Jamerson, Brenda D., et al.. (1994). Venous Irritation Related to Intravenous Administration of Phenytoin versus Fosphenytoin. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 14(1). 47–52. 61 indexed citations
15.
Zarowitz, Barbara J., Peter H. Vlasses, George E. Dukes, et al.. (1993). Pharmacotherapy Specialty Certification Examination. IV. 1992 Results and Process Modifications, Including Recertification. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 13(3). 262–266. 3 indexed citations
16.
Hermann, David, George E. Dukes, Elizabeth K. Hussey, et al.. (1992). Comparison of Verapamil, Diltiazem, and Labetalol on the Bioavailability and Metabolism of Imipramine. The Journal of Clinical Pharmacology. 32(2). 176–183. 22 indexed citations
17.
Miller, William A., George E. Dukes, Péter Gál, et al.. (1992). Recognition of Pharmacotherapy as a Pharmacy Practice Specialty: An Historical Account and View of the Future. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 12(6). 475–476. 2 indexed citations
18.
Dukes, George E.. (1990). Over-the-counter antidiarrheal medications used for the self-treatment of acute nonspecific diarrhea. The American Journal of Medicine. 88(6). S24–S26. 23 indexed citations
19.
Hussey, Elizabeth K., et al.. (1990). Evaluation of the Pharmacokinetic Interaction Between Diazepam and ACC-9653 (a Phenytoin Prodrug) in Healthy Male Volunteers. Pharmaceutical Research. 7(11). 1172–1176. 11 indexed citations
20.
Thompson, Dennis F., et al.. (1989). Do All Histamine2-Antagonists Cause a Warfarin Drug Interaction?. DICP. 23(9). 675–679. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026